The global Therapeutic Plasma Exchange market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely performed in the treatment of various chronic diseases as first line or as second line of therapy or as a supportive treatment.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).
This report includes an overview of the development of the Therapeutic Plasma Exchange industry chain, the market status of Hospitals (Neurological Disorders, Renal Disorders), Specialty Clinics (Neurological Disorders, Renal Disorders), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Therapeutic Plasma Exchange.
Regionally, the report analyzes the Therapeutic Plasma Exchange markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Therapeutic Plasma Exchange market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Therapeutic Plasma Exchange market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Therapeutic Plasma Exchange industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Neurological Disorders, Renal Disorders).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Therapeutic Plasma Exchange market.
Regional Analysis: The report involves examining the Therapeutic Plasma Exchange market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Therapeutic Plasma Exchange market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Therapeutic Plasma Exchange:
Company Analysis: Report covers individual Therapeutic Plasma Exchange players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Therapeutic Plasma Exchange This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Specialty Clinics).
Technology Analysis: Report covers specific technologies relevant to Therapeutic Plasma Exchange. It assesses the current state, advancements, and potential future developments in Therapeutic Plasma Exchange areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Therapeutic Plasma Exchange market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Therapeutic Plasma Exchange market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Neurological Disorders
Renal Disorders
Hematology Disorders
Metabolic Disorders
Others
麻豆原创 segment by Application
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
麻豆原创 segment by players, this report covers
Asahi Kasei
Baxter International
Terumo
B. Braun
Fresenius Kabi
Kawasumi Laboratories
Haemonetics
Cerus
Hemacare
Medica
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Therapeutic Plasma Exchange product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Therapeutic Plasma Exchange, with revenue, gross margin and global market share of Therapeutic Plasma Exchange from 2019 to 2024.
Chapter 3, the Therapeutic Plasma Exchange competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Therapeutic Plasma Exchange market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Plasma Exchange.
Chapter 13, to describe Therapeutic Plasma Exchange research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Therapeutic Plasma Exchange
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Therapeutic Plasma Exchange by Type
1.3.1 Overview: Global Therapeutic Plasma Exchange 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Therapeutic Plasma Exchange Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Neurological Disorders
1.3.4 Renal Disorders
1.3.5 Hematology Disorders
1.3.6 Metabolic Disorders
1.3.7 Others
1.4 Global Therapeutic Plasma Exchange 麻豆原创 by Application
1.4.1 Overview: Global Therapeutic Plasma Exchange 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Ambulatory Surgical Centers
1.5 Global Therapeutic Plasma Exchange 麻豆原创 Size & Forecast
1.6 Global Therapeutic Plasma Exchange 麻豆原创 Size and Forecast by Region
1.6.1 Global Therapeutic Plasma Exchange 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Therapeutic Plasma Exchange 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Therapeutic Plasma Exchange 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Therapeutic Plasma Exchange 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Therapeutic Plasma Exchange 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Therapeutic Plasma Exchange 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Therapeutic Plasma Exchange 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Asahi Kasei
2.1.1 Asahi Kasei Details
2.1.2 Asahi Kasei Major Business
2.1.3 Asahi Kasei Therapeutic Plasma Exchange Product and Solutions
2.1.4 Asahi Kasei Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Asahi Kasei Recent Developments and Future Plans
2.2 Baxter International
2.2.1 Baxter International Details
2.2.2 Baxter International Major Business
2.2.3 Baxter International Therapeutic Plasma Exchange Product and Solutions
2.2.4 Baxter International Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Baxter International Recent Developments and Future Plans
2.3 Terumo
2.3.1 Terumo Details
2.3.2 Terumo Major Business
2.3.3 Terumo Therapeutic Plasma Exchange Product and Solutions
2.3.4 Terumo Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Terumo Recent Developments and Future Plans
2.4 B. Braun
2.4.1 B. Braun Details
2.4.2 B. Braun Major Business
2.4.3 B. Braun Therapeutic Plasma Exchange Product and Solutions
2.4.4 B. Braun Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 B. Braun Recent Developments and Future Plans
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business
2.5.3 Fresenius Kabi Therapeutic Plasma Exchange Product and Solutions
2.5.4 Fresenius Kabi Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Fresenius Kabi Recent Developments and Future Plans
2.6 Kawasumi Laboratories
2.6.1 Kawasumi Laboratories Details
2.6.2 Kawasumi Laboratories Major Business
2.6.3 Kawasumi Laboratories Therapeutic Plasma Exchange Product and Solutions
2.6.4 Kawasumi Laboratories Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Kawasumi Laboratories Recent Developments and Future Plans
2.7 Haemonetics
2.7.1 Haemonetics Details
2.7.2 Haemonetics Major Business
2.7.3 Haemonetics Therapeutic Plasma Exchange Product and Solutions
2.7.4 Haemonetics Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Haemonetics Recent Developments and Future Plans
2.8 Cerus
2.8.1 Cerus Details
2.8.2 Cerus Major Business
2.8.3 Cerus Therapeutic Plasma Exchange Product and Solutions
2.8.4 Cerus Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Cerus Recent Developments and Future Plans
2.9 Hemacare
2.9.1 Hemacare Details
2.9.2 Hemacare Major Business
2.9.3 Hemacare Therapeutic Plasma Exchange Product and Solutions
2.9.4 Hemacare Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Hemacare Recent Developments and Future Plans
2.10 Medica
2.10.1 Medica Details
2.10.2 Medica Major Business
2.10.3 Medica Therapeutic Plasma Exchange Product and Solutions
2.10.4 Medica Therapeutic Plasma Exchange Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Medica Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Therapeutic Plasma Exchange Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Therapeutic Plasma Exchange by Company Revenue
3.2.2 Top 3 Therapeutic Plasma Exchange Players 麻豆原创 Share in 2023
3.2.3 Top 6 Therapeutic Plasma Exchange Players 麻豆原创 Share in 2023
3.3 Therapeutic Plasma Exchange 麻豆原创: Overall Company Footprint Analysis
3.3.1 Therapeutic Plasma Exchange 麻豆原创: Region Footprint
3.3.2 Therapeutic Plasma Exchange 麻豆原创: Company Product Type Footprint
3.3.3 Therapeutic Plasma Exchange 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Therapeutic Plasma Exchange Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Therapeutic Plasma Exchange 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Therapeutic Plasma Exchange Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Therapeutic Plasma Exchange 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Therapeutic Plasma Exchange Consumption Value by Type (2019-2030)
6.2 North America Therapeutic Plasma Exchange Consumption Value by Application (2019-2030)
6.3 North America Therapeutic Plasma Exchange 麻豆原创 Size by Country
6.3.1 North America Therapeutic Plasma Exchange Consumption Value by Country (2019-2030)
6.3.2 United States Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Therapeutic Plasma Exchange Consumption Value by Type (2019-2030)
7.2 Europe Therapeutic Plasma Exchange Consumption Value by Application (2019-2030)
7.3 Europe Therapeutic Plasma Exchange 麻豆原创 Size by Country
7.3.1 Europe Therapeutic Plasma Exchange Consumption Value by Country (2019-2030)
7.3.2 Germany Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Plasma Exchange Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Therapeutic Plasma Exchange Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Therapeutic Plasma Exchange 麻豆原创 Size by Region
8.3.1 Asia-Pacific Therapeutic Plasma Exchange Consumption Value by Region (2019-2030)
8.3.2 China Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Therapeutic Plasma Exchange Consumption Value by Type (2019-2030)
9.2 South America Therapeutic Plasma Exchange Consumption Value by Application (2019-2030)
9.3 South America Therapeutic Plasma Exchange 麻豆原创 Size by Country
9.3.1 South America Therapeutic Plasma Exchange Consumption Value by Country (2019-2030)
9.3.2 Brazil Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Plasma Exchange Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Therapeutic Plasma Exchange Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Therapeutic Plasma Exchange 麻豆原创 Size by Country
10.3.1 Middle East & Africa Therapeutic Plasma Exchange Consumption Value by Country (2019-2030)
10.3.2 Turkey Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Therapeutic Plasma Exchange 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Therapeutic Plasma Exchange 麻豆原创 Drivers
11.2 Therapeutic Plasma Exchange 麻豆原创 Restraints
11.3 Therapeutic Plasma Exchange Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Therapeutic Plasma Exchange Industry Chain
12.2 Therapeutic Plasma Exchange Upstream Analysis
12.3 Therapeutic Plasma Exchange Midstream Analysis
12.4 Therapeutic Plasma Exchange Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Asahi Kasei
Baxter International
Terumo
B. Braun
Fresenius Kabi
Kawasumi Laboratories
Haemonetics
Cerus
Hemacare
Medica
听
听
*If Applicable.
